GOTHENBURG, SE / ACCESS WIRE / October 21, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV) Invitation to participate in XVIVO’s conference call regarding the presentation of the January-September 2022 interim report. The presentation will be held in English.
Time: Thursday, October 27 at 2:00 p.m. CET
To join the conference call from your computer, use the following link:
Conference phone numbers:
Sweden: +46 856642651 PIN: 82398789#
UK: +44 3333000804 PIN: 82398789#
USA: +1 6319131422 PIN: 82398789#
Conference name: XVIVO Interim Report Q3 2022
Christoffer Rosenblad, interim CEO
Kristoffer Nordström, CFO
The press release for the XVIVO January-September 2022 interim report will be published on October 27, 2022 at 7:30 a.m. CET.
Prior to the conference call, slides will be available on the company’s webpage, https://www.xvivoperfusion.com/corporate/financial-presentations/earnings-calls/
October 21, 2022
XVIVO Infusion AB (publ)
For more information, please contact:
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the lifespan of all major organs – so that transplant teams around the world can save more lives. Our solutions enable leading clinicians and researchers to push the boundaries of transplant medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and bears the symbol XVIVO. More information can be found at www.xvivogroup.com.
THE SOURCE: XVIVO Infusion AB
See the source version on accesswire.com: